Literature DB >> 22779342

[Antiinflammatory therapy in ostheoarthritis including omega 3 and omega 6 fatty acids].

Małgorzata Dzielska-Olczak1, Jerzy Z Nowak.   

Abstract

Osteoarthritis (ostheoarthrosis, OA) is characterized by progressive destruction of articular cartilage, remodeling of the periarticular bone and inflammation of the synovial membrane. In patients occur joints pain, impaired joints motion and disability. The results of many studies indicate an inflammation as foundation of this disease. The management of OA include a combination of pharmacological treatments and nonpharmacological interventions. Pharmacological treatments include used paracetamol, nonsteroidal anti-inflammatory drugs (NSAIDs) and chondroprotectives (glucosamine, chondroitin sulfate and so on). NSAIDs long-term use associated with serious adverse effects. OA symptoms are effectively reduced by nutrients such omega 3 and omega 6 fatty acids (PUFAs as EPA, DHA), which decrease the need for non-steroidal drugs and may less adverse events. They exerts, particularly EPA, anti-inflammatory effect, inhibit catabolic processes, stimulate the anabolic process in the cartilage in the joint. Many different evidence validate that omega 3 alleviate the progression of osteoarthritis and have exciting therapeutic potential for preventing cartilage degradation associated with chronic inflammatory in joints.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22779342

Source DB:  PubMed          Journal:  Pol Merkur Lekarski        ISSN: 1426-9686


  2 in total

1.  Comparative Analysis of the Bioactive Compounds in Chicken Cartilage: Protective Effects of Chondroitin Sulfate and Type II Collagen Peptides Against Osteoarthritis Involve Gut Microbiota.

Authors:  Hongru Zhang; Liwei Qi; Qingshan Shen; Ruiqi Wang; Yujie Guo; Chunhui Zhang; Aurore Richel
Journal:  Front Nutr       Date:  2022-03-30

2.  Changes in morphology, gene expression and protein content in chondrocytes cultured on a random positioning machine.

Authors:  Ganna Aleshcheva; Jayashree Sahana; Xiao Ma; Jens Hauslage; Ruth Hemmersbach; Marcel Egli; Manfred Infanger; Johann Bauer; Daniela Grimm
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.